シアトルにおける骨髄移植の動向 臨床治験例を中心として:—臨床治験例を中心として—
スポンサーリンク
概要
- 論文の詳細を見る
During 3 months stay at transplant unit in Seattle, about 80 bone marrow transplants were done.Clinical course of 5 patients, out of 12 whom I took care of as a primary doctor, were presented.In Seattle, long-term survival for patients with ANLL transplanted in first remission were 70% in patients under age 20, 42% in ages 20∼29 and 27% in ages 30∼50. Long-term survival transplanted for ALL in second or subsequent remission were 27%, since recurrence of leukemia was the major problems. Long-term survival for untransfused patients with aplastic anemia was 80%. In patients with aplastic anemia, ATG therapy is an effective alternative for bone marrow transplantation.Recent advance and prospect in Seattle were mentioned.
- 一般社団法人 日本血液学会の論文
一般社団法人 日本血液学会 | 論文
- 健常者ならびに播種性血管内凝固(DIC)例における血漿アンチトロンビンIII (AT-III)の抗トロンビン活性と抗原性の比較
- 新生児の凝固・線溶阻止因子の動態
- All-trans retinoic acid投与中に広範な脳梗塞を生じた急性前骨髄球性白血病
- C/EBPβのショートアイソフォームであるLIPはマウス移植モデルにおいてEvi1と協調作用して急性骨髄性白血病を誘発する
- 成人に発症したビタミンK依存性血液凝固因子欠乏に関する臨床的解析